Is Elicio Therapeutics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: ELTX) stock is to Buy ELTX stock.
Out of 1 analyst, 0 (0%) are recommending ELTX as a Strong Buy, 1 (100%) are recommending ELTX as a Buy, 0 (0%) are recommending ELTX as a Hold, 0 (0%) are recommending ELTX as a Sell, and 0 (0%) are recommending ELTX as a Strong Sell.
What is ELTX's forecast return on equity (ROE) for 2024-2027?
(NASDAQ: ELTX) forecast ROE is N/A, which is considered weak.
What is ELTX's Price Target?
According to 1 Wall Street analyst that have issued a 1 year ELTX price target, the average ELTX price target is $11.00, with the highest ELTX stock price forecast at $11.00 and the lowest ELTX stock price forecast at $11.00.
The Wall Street analyst predicted that Elicio Therapeutics's share price could reach $11.00 by Jan 17, 2025. The average Elicio Therapeutics stock price prediction forecasts a potential upside of 18.92% from the current ELTX share price of $9.25.
What is ELTX's forecast return on assets (ROA) for 2024-2027?
(NASDAQ: ELTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.